A research team at the Korea Research Institute of Bioscience and Biotechnology (KRIBB) has traced dementia-related neurodegeneration to a type of genetic damage that mice simply cannot have. Working with brain organoids grown from human stem cells, Dr. Mi-Ok Lee and Dr. Mi-Young Son of the Stem Cell Convergence Research Center showed how a deletion mediated by Alu elements - short DNA sequences found only in primates - leads to neuronal injury.
Alu elements make up roughly 10 percent of the human genome. When two of them recombine abnormally, the genetic information sitting between them can be wiped out. Because mice carry no Alu elements at all, this entire category of mutation has been effectively invisible to the animal models that have underpinned decades of brain disease research, dementia included.
The team focused on SPAST, a gene whose mutations cause hereditary spastic paraplegia, a disorder marked by leg stiffness and weakness. Some patients carrying large SPAST deletions go on to develop cognitive decline and dementia rather than motor symptoms alone, and why that happens has never been clear. The organoid work offers a route into that question by reproducing the deletion in human brain tissue rather than approximating it in another species.
The broader point extends past one gene. If primate-specific genomic architecture contributes meaningfully to how human neurons degenerate, then some mechanisms behind dementia may not surface in conventional animal experiments at all - and human stem cell-derived models become less a supplement than a necessity for finding them.